Context Therapeutics Inc. (CNTX) News
Follow Context Therapeutics Inc. (CNTX) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 3 public stories across 3 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
CNTX - Context Therapeutics Announces First Patient Dosed in Phase 1 Trial of CT-202
CNTX - Context Therapeutics Announces First Patient Dosed in Phase 1 Trial of CT-202
EQUITY | Sep 09, 2026, 11:30 AM UTC
L
Why SiTime Shares Are Trading Higher By Over 30%; Here Are 20 Stocks Moving Premarket
Shares of SiTime Corp (NASDAQ: SITM ) rose sharply in pre-market trading after the company reported better-than-expected second- quarter financial results. SiTime reported quarterly earnings of $2.34 per share which beat
EARNINGS | Aug 06, 2026, 08:55 AM UTC
M
Context Therapeutics Reports Q2 Progress
Context Therapeutics reports Q2 operating progress
EQUITY | Aug 05, 2026, 08:14 PM UTC